BiotechTube

Longeveron Mesenchymal Stem Cells

Phase 1/2UNKNOWN
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

HLHS

Conditions

HLHS

Trial Timeline

Feb 21, 2018 → Dec 31, 2025

NCT ID
NCT03525418

About Longeveron Mesenchymal Stem Cells

Longeveron Mesenchymal Stem Cells is a phase 1/2 stage product being developed by Longeveron for HLHS. The current trial status is unknown. This product is registered under clinical trial identifier NCT03525418. Target conditions include HLHS.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT03525418Phase 1/2UNKNOWN

Other Products from Longeveron

Allogeneic MSCPhase 2
44
Longeveron Mesenchymal Stem Cells (LMSCs)Phase 2
44
Lomecel-B medicinal signaling cellsPhase 2
44
Peripheral Intravenous (IV) infusion of LMSCsPhase 2
44
Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) + Placebo + Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)Phase 1/2
33